Etcembly ^Companies

The company design and engineering using generative artificial intelligence to bridge the gap between machine learning and traditional drug discovery and specializes in rapid in silico design and engineering for bispecific T-cell engagers for oncology and autoimmunity through its engine, EMLy (Etcembly Machine Learning), enabling researchers to deliver new diagnostics and represent a novel paradigm in lean drug development.Etcembly Company Profile: Valuation, Funding & Investors | Pitch…pitchbook.com/profiles/company/434090-71